
Sign up to save your podcasts
Or
Harlan Krumholz, MD, FACC, JACC Editor-in-Chief, and Benjamin M. Scirica, MD, MPH, FACC, discuss the surprising benefits of semaglutide beyond weight loss and cardiovascular health from the SELECT trial, which investigated the effects of semaglutide on COVID-19 outcomes and non-cardiovascular deaths in patients with obesity and cardiovascular disease.
4.2
154154 ratings
Harlan Krumholz, MD, FACC, JACC Editor-in-Chief, and Benjamin M. Scirica, MD, MPH, FACC, discuss the surprising benefits of semaglutide beyond weight loss and cardiovascular health from the SELECT trial, which investigated the effects of semaglutide on COVID-19 outcomes and non-cardiovascular deaths in patients with obesity and cardiovascular disease.
131 Listeners
325 Listeners
864 Listeners
496 Listeners
22 Listeners
31 Listeners
3,336 Listeners
90 Listeners
138 Listeners
1,095 Listeners
61 Listeners
39 Listeners
185 Listeners
349 Listeners
427 Listeners